Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene (RET) Peptid

RET Reaktivität: Human Wirt: Synthetic BP
Produktnummer ABIN2711884
  • Target Alle Ret Proto-Oncogene (RET) Produkte
    Ret Proto-Oncogene (RET)
    Spezies
    Human
    Quelle
    • 5
    Synthetic
    Applikation
    Blocking Peptide (BP)
    Produktmerkmale
    The peptide is used to block Anti-RET Antibody reactivity.
  • Applikationshinweise
    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Shipped at 4°C. Store at -20°C for one year.
    Haltbarkeit
    12 months
  • Target
    Ret Proto-Oncogene (RET)
    Synonyme
    c-ret Peptide, cret Peptide, etID315074.13 Peptide, ret1 Peptide, wu:fd13h01 Peptide, X-ret Peptide, ret-A Peptide, xret Peptide, RET Peptide, MTC1 Peptide, CDHF12 Peptide, CDHR16 Peptide, HSCR1 Peptide, MEN2A Peptide, MEN2B Peptide, PTC Peptide, RET-ELE1 Peptide, RET51 Peptide, RET9 Peptide, c-Ret Peptide, ret proto-oncogene receptor tyrosine kinase Peptide, ret proto-oncogene S homeolog Peptide, ret proto-oncogene Peptide, ret Peptide, ret.S Peptide, RET Peptide, Ret Peptide
    Hintergrund
    CDHF12, CDHR16, PTC, RET51, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret
    Gen-ID
    5979
    UniProt
    P07949
Sie sind hier:
Kundenservice